Автореферат и диссертация по медицине (14.00.13) на тему:Факторы, определяющие качество жизни у больных с дисциркуляторной энцефалопатией и их коррекция

1. Алиев А.А. Ишемический инсульт в вертебрально-базилярной системе. Дисс. . докт. мед. наук. М., 2000.

2. Атарщикова М.В. Клопидогрель (плавике) снижает риск развития ишемических осложнений у больных с атеросклерозом. Журн. невропатол. и психиатр. Инсульт 2001; 1: 58-63.

3. Атаян А.В. Диагностика и лечение больных с головокружением различного генеза. Дисс. . канд.мед. наук. М., 2001.

4. Бадалян Л.О. Неврологические синдромы при болезнях сердца. -М. Медицина, 1975.

5. Валунов О.А., Демиденко Т.Д., Львова Р.И. К вопросу оценки эффективности реабилитации больных с последствиями инсульта. Журн. невропатол. и психиатр 1996; 5: 102- 106.

6. Бекузарова М.Р. Выраженные клинические формы недостаточности мозгового кровообращения. Дис . док. мед. наук., М., 1997.

7. Бердичевский М.Л. Венозная дисциркуляторная патология головного мозга. М., Медицина, 1989; 362 с.

8. Бурд Г.С., Гехт А.Б., Боголепова А.Н. Ноотропил в лечении расстройств высших мозговых функций у больных с ишемическим инсультом. Журн. невропатол. и психиатр 1997; 10: 29 35.

9. Верещагин Н.В. Патология вертебрально-базилярной системы и нарушения мозгового кровообращения. М., 1980.

10. Верещагин Н.В., Моргунов В.А., Гулевская Т.С. Патология головного мозга при атеросклерозе и артериальной гипертонии. М.: Медицина, 1997. 288с.

11. И. Виленский B.C., Семенова Г.М., Широков Е.А. Применение церебролизина при ишемическом инсульте. Журн. неврол. и психиатр. 1999; 4: 65-69.

12. Воловец С.А. Клинико-гемодинамические особенности больных с сочетанными окклюзирующими поражениями магистральных артерий головы на поздних стадиях дисциркуляторной энцефалопатии. Дисс. канд. мед. наук. М, 1995; 153 с.

13. Ганнушкина И.В., Лебедева Н.В. Гипертоническая энцефалопатия. М., 1987. С. 121-124.

14. Гнездицкий В.В., Калашникова Л.А., Бараш A.C. и др. Анализ ЭЭГ при когнитивных нарушениях и деменции коркового и подкоркового типов у больных с цереброваскулярными заболеваниями. Неврологический журнал 1997; 6: 33-41.

15. Горбачева Ф.Е., Скоромец A.A., Яхно H.H. Сосудистые заболевания головного мозга. В кн.: Болезни нервной системы. Руководство для врачей. T.I. -М.: Медицина, 1995; 152-255.

16. Гулевская Т. С, Людковская И.Г. Артериальная гипертония и патология белого вещества головного мозга. Арх. пат. 1992; 2: 53-59.

17. Гусев Е.И. Ишемическая болезнь головного мозга. Актовая речь. М. 1992.

18. Гусев Е.И., Бурд Г.С., Гехт А.Б., Скворцова В.И., Метаболическая терапия ишемического инсульта. Журн. неврол. и псих. 1997; 10: 24-28.

19. Гусев Е.И., Скворцова В.И. Нейропротективная терапия острого ишемического инсульта. Человек и лекарство. Тезисы докладов. 1998; 54.

20. Гусев Е.И., Бурд Г.С., Гехт А.Б. и соавт. Метаболическая терапия ишемического инсульта: применение ноотропила. Журн. неврол. и психиатр. 1997; 10: 24-35.

21. Гусев Е.И., Коновалов H.A., Беляков В.В. и соавт. Методы исследования в неврологии и нейрохирургии. М.: "Нолидж", 2000, 334 с.

22. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М . 2000; 322 с.

23. Гонзова И,П. Кардиальные дисфункции в клинике сосудистой энцефалопатии. В кн.: VII Всероссийский съезд неврологов (тезисы докладов). -Новгород, 1995. N.202

24. Дамулин ИВ. Дисциркуляторная энцефалопатия в пожилом и старческом возрасте. Дисс. . докт. мед. наук. М., 1997.

25. Дамулин И.В. Современные подходы к лечению болезни Альцгеймера. Журн. неврол. и психиатр. 1998; 12: 56-61.

26. Жирмунская Е.А., РухмановА.А. Электроэнцефалографическая характеристика дисциркуляторной энцефалопатии. Журн. невропатол. и психиатр. 1991; 1: 35-38.

27. Захаров В.В., Ахутина Т.В. Особенности нарушений памяти при болезни Альцгеймера и болезни Паркинсона. В кн.: Достижения в нейрогериатрии. Под ред Н.Н.Яхно, И.В.Дамулина. М. 1995. С. 131-156.

28. Зыков В.П. Церебральная гемодинамика у больных дисциркуляторной энцефалопатией Дис. канд. мед. наук. М. 1990.

29. Иванов Ю.С., Сёмин Г.Ф. Цереброваскулярная реактивность в патогенезе ишемических поражений мозга у больных разного возраста. Журн. невропатол. и психиатр. 1996; 5: 19-24.

30. Кабанов A.A. Состояние церебральной гемодинамики у больных с дисциркуляторной энцефалопатией и её медикаментозная коррекция. Дисс. . канд. мед. наук. М., 1993.

31. Кадыков A.C. "Восстановление после инсульта Вестник практической неврологии (Москва). -1995. -N.I. -С.72-73

32. Казаков А.Ю. Патогенез и вопросы медикаментозной терапии дисциркуляторной энцефалопатии. Дис. . канд. мед. наук. М., 1989.

33. Калашникова Л.А., Гулевская Т.С., Кадыков A.C., Шахпаронова Н.В. Субкортикальная артериосклеротическая энцефалопатия (клинико-морфологическое исследование). Неврологический журнал 1998; 2:7-13.

34. Калашникова Л.А., Гулевская Т.С., Кашина ЕМ. Нарушение высших психических функций при локализации одиночных инфарктов в зрительном бугре и в области таламофронтальных путей. Невропатология и психиатрия 1998; 6: 8-13.

35. Камчатнов П Р. Расстройства мозгового кровообращения у лиц молодого и среднего возраста с инфарктом миокарда. Дисс. . канд. мед. наук., М. 1986.

36. Камчатнов П.Р. Вертебрально-базилярная недостаточность. Дисс. . . . д. м. н. М., 2001.

37. Камчатнов П.Р., Гордеева Т.Н., Кабанов A.A., Каралкин A.B., Абусуева Б. А. Клинико-патогенетические особенности синдрома вертебрально-базилярной недостаточности. Журнал невропатол. и психиатр. 2001; 1: 44-48.

38. Краснощекова Л.И. Клинико-морфологические параллели сочетанной патологии сердца и сосудов головного мозга. В кн.: Соматогенные нарушения мозгового кровообращения. Сб. научи, трудов., М., 1984; 21-26.

39. Лебедева A.A., Гапеева Л.С. К определению профессиональной пригодности больных с НГШКМ. Журн. неврол. и психиатр. 1989; 89; 1: 34-38.

40. Левина Г.Я., Гулевская Т.С. Прогрессирующая субкортикальная артериосклеротическая энцефалопатия (болезнь Бинсвангера). Арх. пат. 1985; 8: 70-73.

41. Левин О.С., Дамулин ИВ. Диффузные изменения белого вещества (лейкоареоз) и проблема сосудистой деменции В кн: Достижения в нейрогериартрии. М., Изд-воММАим. И М. Сеченова, 1995; 1: 189-232.

42. Мартынов М.Ю. Хроническая мозговая сосудистая недостаточность и ишемический нсульт. Дисс. докт. мед. наук М., 2000.

43. Медведева М.В., Яхно H.H. Вегетативная нервная система и старение. Журн. неврол. и психиатр. 1994;94; 4: 95-99.

44. МКБ X. Международная статистическая классификация болезней и проблем, связанных со здоровьем. ВОЗ. Женева. М. 1995.

45. Мякотных B.C., Стариков A.C., Хлынов В.И. Нейрососудистая гериатрия. -Екатеринбург: УИФ Наука, 1996.

46. Стулин И.Д., Карлов В.А., Костин A.B. и соавт. Транскраниальная допплерография у здоровых людей. Журн. невропатол. и психиатр. 1988;2:49-56.

47. Шахнович А.Р., Шахнович В.А. Диагностика нарушений мозгового кровообращения. Транскраниальная допплерография. М., 1996.

48. Шмидт Е.В. Классификация сосудистых поражений головного и спинного мозга. Журн. невропатол. и психиатр. 1985; 9: 1281-1288.

49. Шмидт E.B. Дисциркуляторная энцефалопатия. В кн.: Клиническая гериатрия: (Учебное пособие для врачей). Под ред. B.C. Гасилина, АС. Мелентьева. М., 1986. -С.29-40.

50. Шмырев В.И., Пожидаева НВ., Архипов С.Л, Артамонов А.В. Сосудистые и опухолевые заболевания мозга с обратимым неврологическим дефицитом (транзиторные ишемические и опухолевые атаки). Клинический вестник. 1995; 2: 9-10.

51. Яхно Н.Н. Актуальные вопросы гериартрии. Достижения в нейрогериартрии, т. 1., М., изд-во ММА им. И М. Сеченова, 1995 с. 9-30.

52. Akdemir I, Dagdelen S, Yuce M, Davutoglu V, Akcay M, Akdemir N, Aksoy M, Erkal H, Misirli H. Silent brain infarction in patients with rheumatic mitral stenosis. Jpn Heart J 2002 Mar;43(2): 137-44

53. Alexopoulos G.S. Heterogeneity and comorbidity in dementia-depression syndromes. Int JGeriatr. Psychiatry. 1991; 6: 125-127.

54. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with «reversible dementia»: a controlled study. Am J Psychiatry. 1993;150: 1693-1699.

55. Alom J. Clinical forms of vascular dementia. In: Culebras A., Mafias Guiu J., Roman G. New concepts in vascular dementia. Barcelona: Prous Science Publishers, 1993. -P. 71-77.

56. Alvarez Perez F, Segura Martin T, Serena Leal J, Osuna Pulido T, Castellanos Rodrigo M, Silva Bias Y, Davalos Errando A. The normal values of the haemodynamic reserve (HR) evaluated by the СОг test. Neurologia 2002 May;17(5):231-236

57. Ancill R. J. Cognitive-affective disorders: the co-presemtation of depression and dementia in the elderly. Canadian consensus symposium of depression. Psychiatr J UnivOtt. 1998; 14:370-371.

58. Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Quality of Life Research 1993; 2:369395.

59. Angst J. Epidemiology of depression. Psychopharmacology. 1992; 106 (suppl): S71-S74.

60. Babikian V. and Ropper A.H. Binswanger's Disease A Review. Stroke 1987; 18(1): 2-12.

61. Baron J.C., Desgranges B., Landeau B. et al. Memory impairment and synaptic alterations in aging: mapping with PET. Europ. J. Neurol. 1997; 1; 4; SuppL I: S40.

62. Bell DS, Kahn CE Jr. Assessing health status via the World Wide Web. In: Cimino JC, ed. Proceedings of the AMIA Annual Fall Symposium. Philadelphia: Hanley & Belfus, 1996: 338-342.

63. Blauw G.J., Lagaay AM, Smelt AHM, Westendorp RGJ. Stroke, statins, and cholesterol. Stroke 1997; 28: 946-950

64. Bernascolli A., Bogousslavski J. Multiple acute Infarctions in the posterior Circulation. J. Neurol. Neurosurg. Pscychiatr. 1996; 60: 289-296.

65. Bombardier C. Outcome assessments in the evaluation of treatment of spinal disorders. Spine 2000;25:3097-3099.

66. Boone K.B., Miller B.L., Lesser I.M. et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect. Arch. Neurol. 1992; 49: 549-554.

67. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305:160-4.

68. Breteler M.B., van Swieten J.C., Bots M.L. et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study. The Rotterdam Study. Neurology 1994; 44:1246-1252.

69. Brun A. Cerebral hypoperfusion and dementia: pathoanatomical aspects. In: 7 1PA Congress. Sydney, Australia, 1995. Abstracts. -P.39.

70. Bruno A., Biller G. Silvidi A. A reason for failure to obtain transcranial Doppler flow signal. Stroke. 1988; 19: 274-281

71. Buntix F, Kester A, Bergers J, Knottnerus JA. Is depression in elderly people followed by demential A retrospective cohort study based in general practice. Age Ageing. 1996; 25: 231-233.

72. Camicioli R., Panzer-Decius V., Kaye J. Balance performance in the very old: posturography and clinical assessment. Neurology. 1994; 44: 4: 2: 63.

73. Caplan L.R. Binswanger's disease revisited. Neurology 1995; 45: 626-633.

74. Caplan L.R., Hennerici M. Emboli (Washout), Hypoperfusion, Embolism, Ischemic Stroke. Arch Neurol. 1998; 55:1475-1482.

75. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.

76. Carlson L.A., Gottfries C.G., Winblad B. Introduction. In: Vascular Dementia. Etiological, Pathogenetic, Clinical and Treatment Aspects. Ed. by L.A.Carlson, C.G.Gottfries, B. Winblad. -Basel etc.: S.Karger, 1994. -P.I.

77. Chen C.C., Manning A.M. . Novel molecular correlates of neuronal death and regeneration Cytokine 1996;8: 1: 58-65.

78. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, Pessin MS, Weichel E, Sila CA, Furlan AJ, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology. 1995 Aug;45(8): 1488-93.

79. Chui H.C., Victoroff J.I., Margolin D. et al. Criteria for the diagnosis of lischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. -1992. -Vol.42, N.3. -P.473-480.

80. Chung C-S. Caplan L.R., Han W. et al. Thalamic haemorrhage. Brain 1996; 119: 1873-1886.

81. Cholesterol and strokes. Editorials BMJ 2000;320:459-460.

82. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Antithrombotic Trialists' Collaboration. BMJ 2002;324:71-86.

83. Cotr R, Battista RN, Abrahamowicz M, et al. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. Ann Intern Med 1995;123:649-655.

84. Cristina S., Nicolosi A.M., Hauser W.A. et al. The prevalence of dementia in a rural population of northern Italy: a door to door survey. Europ. J. Neurol. 1997; 4; SuppL I; S58.

85. Crouse J., Byington R., Furberg C. HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trail data. Atherosclerosis 1998; 138: 1124.

86. Crymy M., Ryglewicz D., Czlon.kowska A. Cognitive impairment in stroke survivors in correlation with risk factors of vascular diseases and brain lesions in CT. Europ. J. Neurol. 1997; 4; Supp I: P.S59.

87. Cummings J.L. Vascular subcortical dementias: Clinical aspects. In: Vascular Dementia. Etiological, Pathogenetic, Clinical and Treatment Aspects. Ed. by L.ACarlson, E.G.Gottfries, B.Winblad. -Basel etc.: S.Karger, 1994. -P.49-52.

88. CURE Study Investigators. Effects of Clopidogrel in addition to aspirin in patients with non-ST segment elevation acute coronary syndromes. N Engl J Med 2001;345:494-502.

89. De Deyn P.P., Reuck J.D., Deberdt W„ Vlietinck R., Orgogozo J.M. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group. Stroke. 1997; 28(12): 2347-2352.

90. Downs J R., Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998; 279: 16151622

91. Drieu K. Preparation and Definition de lAextrait Ginkgo Biloba.Presse Med. 1986; 31: 1455-1457.

92. Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. Stroke 2000;31:1429-438.

93. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol and stroke in eastern Asia. Lancet 1998; 352: 1801-1807.

94. Eastwood R,, Graham J., Nobbis-Driver H. "The Canadian study of health & aging: prevalence of dementia and cognitive impairment no dementia". In: 7 IP A Congress. Sydney, Australia, 1995. Abstracts. -P.95.

95. Englund E. Hypoperfusive white matter disease and hypotension in dementia, hi: 7IPA Congress. Sydney, Australia, 1995. Abstracts. -P.44.

96. Ehiistahl S., Rosen 1. Postural hypotension and EEG variables predict cognitive decline: Results from a 5-year follow-up of healthy elderly women. Dementia and Geriatric Cognitive Disorders. -1997. -Vol. 8. -P. 180-187.

97. Emery V.O.B., Gillie E.X., Smith I Reclassification of the vascular dementias: Comparisons ofinfarct and noninfarct vascular dementias. In: 7th IPA Congress. Sydney, Australia, 1995. Abstracts. -P. 7.

98. Emery V.O.B., Gillie EX., Smith J. Cognitive dysfimction in infarct and noninfarct vascular dementias. In: 7th IPA Congress. Sydney, Australia, 1995. Abstracts. P. 89.

99. Emery V.O.B., Gillie E.X., Smith J.A. Reclassification of the vascular dementias. Comparisons of infarct and noninfarct vascular dementias. Internal Psychogeriatr. -1996. -Vol.8, N.I. -P.33-61.

100. Erkmjuntti T., Haltia M., Palo S. et al. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J. Neurol. Neurosurg. Psychiatry 1988; 51(8): 1037-1044.

101. Erkinjuntti T. Clinical criteria for vascular dementia: The NINDS-AIREN I criteria. In: Vascular Dementia. Etiological, Pathogenetic, Clinical and Treatment

102. Aspects. Ed. by L.A.Carlson, C.G.Gottfries, B.Winblad. -Basel etc.: S.Karger, 1994. 61-64.

103. Erkinjuntti T. Subcortical vascular dementia diagnostic problems. In: 7 IPA agress. Sydney, Australia, 1995. Abstracts. -P. 45.

104. Erkinjuntti T., Benavente O., Eliasziw M. et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch. Neurol. 1996; 53:325-332.

105. ESPS 2 Group. European stroke prevention study. 2. Efficacy and safety data. J Neurol Sci 1997;151(suppl):Sl-77.

106. Ferrante L., Mastronareli L., Acqui M. Mutism after posterior surgery in children. J. Neurosurg. 1990; 72: 959-063.

107. Fisher C.M. Binswanger's encephalopathy: a review. J. Neurol. 1989; 236: 6579.

108. Fisher M. Risk factors and potential interventions for vascular dementia. In: Culebras A., Matias Guiu J., Roman G. New concepts in vascular dementia. Barcelona: Prous Science Publishers, 1993; 9-17.

109. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient.based outcome measures for use in clinical trials. Health Technol Assess 1998;2:1.74.

110. Folstein M., Bylsma F. In: Terry R., Catsman R., Bick K. (eds.) AlzheimerAs disease. Raven Press, NY. 1994; 27-40.

111. Foulkes M.A., Wolf P.A., Price T R. et al. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988; 19: 547-554.

112. Fraysse B., Bebear J., Dubreuil C. Betahistine dihydrochloride versus Flunarisine. Acta Otolaryngol. 1991; 479: 24-28.

113. Furberg CD, Adams HP, Applegate WB, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994;90:1679-1687.

114. Furberg C.Natural Statins and Stroke Risk Editorials Circulation. 1999;99:185-188

115. Gallassi R., Morreale A., Montagna P. et al. Binswangens disease and normal-pressure hydrocephalus. Arch. Neurol. 1991; 48: 1156-1159.

116. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993; 306:1440-1444.

117. Garratt AM, Schmidt L, Fitzpatrick R. Patient.assessed health outcome measures for diabetes: a structured review. Diabet Med 2002; 19:1.11.

118. Garratt AM, Schmidt L, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures BMJ 2002;324:1417-1419.

119. Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1:1215- 1220.

120. Gottfries C,G. Depression and Alzheimer disease, from molecular biology to therapy. Birkhauser, Boston. 1996; 27-40.

121. Gropen T., Tatemichi T., Figueroa M et al. Course and predictors of cognitive recovery in the first three months after stroke. Neurology. 1994; .44: 4: 2: 328.

122. Guberman A., Stuss D. The syndrome of bilateral paramedian thalamic infarction. Neurology 1983; 33:540-546.

123. Gustafson L., Brun A., Edvinsson L. et al. Cerebral hypoperfusion and dementia. In: 7 IPA Congress. Sydney, Australia, 1995. Abstracts. -P.47

124. Hachinski V.C., Lassen N.A,, Marshall J. Multi-infarct dementia. A case of (mental deterioration in the elderly. Lancet. -1974;2: 207-210.

125. Hachinski V.C. Rethinking vascular dementia. In: CulebrasA., Matias Guiu J., Roman G. New concepts in vascular dementia. Barcelona: Prous Science Publishers, 1993. -P.95-101.

126. Hachinsky V. Vascular dementia: A radical redefinition, In: Vascular Dementia. Etiological, Pathogenetic, Clinical and Treatment Aspects. Ed. by L.A.Carlson, C.G.Gottfries, B.Winblad. -Basel etc.: S.Karger, 1994. -P.2-4.

127. Halumen T., Hatlikainen M., Koivisto K- et al. A follow-up study of subjects with age-associated memory impairment. Neurology. 1994; .44; 4; Suppl.2: 143.

128. Harker LA, Boissel JP, Pilgrim AJ, Gent M. Comparative safety and tolerability of clopidogrel versus aspirin. Results from CAPRIE. Drug Safety 1999; 21:325-35.

129. Hart RG, Harrison MJG. Aspirin wars: the optimal dose of aspirin to prevent stroke. Stroke. 1996;27:585-587.

130. Hart R., Halperin J., McBunde R. Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch. Neurol 2000; 57: 326-332.

131. Hass WK, Easton JD, Adams HP. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-507.

132. Hayes J A, Black NA, Jenkinson C, Young JD, Rowan KM, Daly K, et al. Outcome measures for adult critical care: a systematic review. Health Tech. nol Assess 2000; 4:1.111.

133. Hebert PR, Gaziano JM, Hennekens CH. An overview of trials of cholesterol lowering and risk of stroke. Arch Intern Med. 1995;155:50-55.

134. Hebert P.R., Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drug, risk of stroke, and total mortality. JAMA 1997; 278: 313-321.

135. Herbert JM, Lemat A, Samama M, Maffrand JP. The antiaggregating and antithrombotic activity of ticlopidine. Thromb Haemost 1996;76:94-8.

136. Herrmann W.M., Dietrich B., Hiersemenzel R. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine-in patients with organic brain syndrome.Int. J. Clin. Pharmacol. Res. 1990: 10: 81-4.

137. Hershey L.A., Olszewski W.A. Ischemic vascular dementia. In: Handbook of Demented Illnesses. Ed. by J.C.Morris. -New York etc.: Marcel Dekker, Inc., 1994. -P.335-351.

138. Herholz K., Heindel W., Rackl A. et al. Regional cerebral blood flow in patients with leuko-araiosis and atherosclerotic carotid artery disease. Arch. Neurol. 1990; 47: 392-396.

139. Hersley L. Dementia associated with stroke. Stroke 1990; 21suppl 2. 9: 9-11.

140. Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ 2001;322:1297-1300.

141. Hoffenberth B., Brune G., Sinzev G. Vascular Brainstem Disease. Basel, 1990.

142. Hofinan A., Claus J., Grobbe D., Breteler M. Atherosclerosis and cognitive function. Neurology. 1994; 44; 4; Suppl.2: P.A365.

143. Hulette C, Nochlin D, McKeel D. et al. Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases. Neurology 1997; 48: 668-672.

144. Hunerbein R., Reuter P., Meyer W., Kuhn F.P. Rofo Fortschr. Geb. Rontgenstr. Neuen. Bildgeb. Verfahr 1997; 167; 612-618.

145. Illuminati G., Calio F.G., Bertagni A., Vietri F., Martineiii V. Riv Eur Sei MedFarmacol 1996; 5-6; 213-216.

146. Jellinger K.A., Bancher C. Classification of dementias based on functional morphology. In: New Trends in the Diagnosis and Therapy of Alzheimer's Disease. K.A. Jellinger, G.Ladurner, M.Windisch (eds). Wien, New York Springer-Verlag, 1994; 9-39.

147. Jenkinson C, Wright L, Coulter A. Criterion validity and reliability of the SF-36 in a population sample. Quality of Life Research 1994; 3.7-12.

148. Juniper EF, Guyatt GH, Ferne PJ, Griffith LE. Measuring quality of life in asthma. Am Rev RespirDis 1993;147:832.8.

149. Katz D.I., Alexander M.P., Madell A H. Dementia following strokes in the mesencephalon and diencephalon. Arch. Neurol. 1987; 44: 1127-1133.

150. Kawas C., Corrada-Bravo M., Metter J., Resnik S. Neuropsychological differences 20 years before death in subjects with and without Aizheimer's pathology. Neurology. 1994; 44; 4, Suppl.2: A141.

151. Kinkel W.R., Jacobs L., Polachini 1. et al. Subcortical arteriosclerotic encephalopathy (Binswanger's disease): computed tomographic, nuclear magnetic resonance, and clinical correlations. Arch. Neurol. 1985; 42: 951-959.

152. Kobayashi S. The relation of hypertension to vascular dementia. In: Dementia: presentation, differential diagnosis and nosology. Ed. by V.OIga B. Emergy and Th.E.Oxman. Baltimore, The Johns Hopkins University Press, 1994. -P. 195-207.

153. Koennecke H.C., Mast H., Troico S., Sacco R. Microemboli in patients with vertebrobasilar ischemia: association with vertebrobasilar and cardiac lesion. Stroke. 1997; 28(3): 593-596.

154. Korczyn A.D. "The clinical differential diagnosis of dementia: Concept and methodology". Psychiatric Clinics North America. 1991; 14; 2. 237-249.

155. Kotila M., Numminen H., Waltimo. Secondary depression in patients after stroke. Results of FINNSTROKE investigation. Stroke. 1998; 29: 368-372.

156. Lainez A., Rieger S.J. Methological problems in clinical studies on vascular dementia. In: Culebras A., Mafias Guiu J., Roman G. New concepts in vascular dementia. Barcelona: Prous Science Publishers, 1993. -P. 115-121.

157. Le Bars P. L., Katz M M., Berman N., Itil T. M., Freedman A. M., Schatzberg A.F. A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia. JAMA. 1997; 278:1327-1332

158. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Kalon KL, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998;339:1665-71.

159. Loeb C., Gandolfo C., and nino G. Intellectual impairment and cerebral lesions in multiple cerebral infarcts. A clinical-computed tomography study. Stroke 1988; 19: 560-565.

160. Longstreth W.T., Manolio T.A., Arnold A. et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The cardiovascular health study. Stroke 1996; 26:1274-1282.

161. Lopez 0., Becker J. Pattern of progression in Aizheimer's disease. In: Dementia and cognitive impairments. Eds.Vellas B. J. et al. Facts and research in gerontology. 1994 (Supplement). -P. 53-63.

162. Lucchelli P., Muggia S. and Spinnier H. The 'Petites Madeleines' phenomenon in two amnesic patients. Sudden recovery of forgotten memories. Brain 1995; 118: 167-183.

163. MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J, et al. Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis. Circulation 1998; 97: 1784-1790.

164. Matsushita K., Kiriyama Y., Nagatsuka K. et al. Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension 1994; 23:565-568.

165. McHorney CA, Ware JJ, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care 1993; 31:247-63.

166. McHorney CA, Kosinski M, Ware JJ. Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey. Medical Care 1994; 32:551-567.

167. Mead GE, Lewis SC, Wardlaw JM, Dennis MS, Warlow CP. Severe ipsilateral carotid stenosis and middle cerebral artery disease in lacunar ischaemic stroke: innocent bystanders? J Neurol 2002;249(3):266-271.

168. Meder J.F., Chiras J., Roland J., Guinet P., Bracard S., Bargy F J Neuroradiol 1994;21;118-133.

169. Meyer J.S., McClintic K.L., Rogers R.L. et al. Aetiological consigerations and risk factors for multi-infarct dementia. J. Neurol. Neurosurg. Psychiatry. 1988; 1: 1489-1497,

170. Mieike R., Kessler J., Szelies B. et al. Vascular dementia: perfiisional and metabolic disturbances and effect:; of therapy. J. Neural. Transm. 1996; suppi. 47: 183-191.

171. Moody D.M., Santamore W.P., Bell M.A. Does the tortuosity in cerebral arterioles impairs down-autoregulation in hypertensive and elderly normotensive? A hypothesis and computer model. Clin. Neurosurg. 1990; 37: 372-387.

172. More RS, Chauhan A. Antiplatelet rather than anticoagulant therapy with coronary stenting. Lancet 1997;349:146-7.

173. Moroney J.T., Bagiella E., Desmond D.W. et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997; 49: 1096-1105.

174. Mortel K.F., Meyer I.S., Sims P.A., McClintic K. Diabetes mellitus as a risk factor for stroke. Southern Med. J. 1990; 83; 8: 904-911.

175. Mortel K.F., Wood S., Pavol M.A. et al. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease. Angiology. -1993. -N.8. -P. 599-605

176. Muller-Spahn F., Hock C. Clinical presentation of depression in the elderly. Gerontology 1994; 40 (sup.): 10-14.

177. Muller-Spahn F. Depression in the elderly. WPA Meetings 1999; 18; 4: 3-6.

178. O'Brien M.D. Vascular disease and dementia. In: Dementia and cognitive impairments. Eds.Vellas B. J. et al. Facts and research in gerontology. 1994 (Supplement); P: 137-141.

179. O'Brien J., Ames D., Desmond P. et al. Is hippocampal atrophy on MRI a marker for Aizheimer's disease? In: 7 IPA Congress. Sydney, Australia, 1995. Abstracts. P. 121.

180. Olofsson H. "Orthostatic hypotension and demented patients". In: 7th IPA Congress. Sydney, Australia, 1995. Abstracts. -P. 122.

181. Oster M., Cohen S.A., Schnulle P. et al. Vascular risk factors in the development of subcortical vascular encephalopathy. Cerebrovasc. Dis. 1995; 5; 4: 270.

182. Padovani A., Di Piero V., Giannini M. et a'. Clinical determinants of dementia 1 stroke patients. J. Neurology. 1994; 241; Supp I: S 127.

183. Pantoni L„ Garcia J.H. The Significance of cerebral white matter abnormalities 100 years after Binswanger's report. A Review. Stroke 1995; 26: 12931301.

184. Pantoni L., Garcia J.H. Pathogenesis of Leukoaraiosis. A Review. Stroke 1997; 28: 652-659.

185. Peto R., Gray R., Collins R. Randomised trial of prophylactic daily aspirin use in Brirish male doctors. B.M.J. 1989; 296: 313-316.

186. Pliillips S. Is atrial fibrillation an independent risk factor for stroke? Canad. J. Neurol. Sci.; 1990; 17: 2: 163-168.

187. Pohjasvaara T., Erkinjuntti T., Vataja R., Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) Cohort. Stroke 1997; 28: 785-792.

188. Pop G., Koudstaal P., Meeder H. et al. Predictive value of clinical history and electrocardiogram in patients with transient ischemic attack or minor stroke for subsequent cardiac and cerebral ischemic events. Arch. Neurol. 1994: 51: 4: 333-341.

189. Ringelstein E. Transcranial Doppler ultrasonography and hyperostosis of the skull. Stroke. 1988; 19: 1445-1449.

190. Roman G.C. Senile leukoencephalopathy, Binswanger's disease and normal-pressure hydrocephalus. In: Culebras A., Matias Guiu J., Roman G. New concepts in ivascular dementia. Barcelona: Prous Science Publishers, 1993. -P.89-93.

191. Roman G.C., Tatemichi T.K., Erkinjuntti T. et al. Vascular dementia: agnostic criteria for research studes. Report of the NINDS-AIREN Work Group. Neurology. 1993; 43: 250-260.

192. Roman G.C. Vascular dementia. NINDS-AIREN diagnostic criteria. In: Culebras A., Matias Guiu J., Roman G. New concepts in vascular dementia. Barcelona: Prous Science Publishers, 1993. -P. 1-7.

193. Rosenberg G.A., Kornfeld M., Stovring J., Bicknell J.M. Subcortical arteriosderotic encephalopathy (Binswanger): Computerized tomography. Neurology 1979; 29: 1102-1106.

194. Ruta DA, Garratt AM, Russell IT. Patient centred assessment of quality of life for patients with four common conditions. Qual Health Care 1999;8:22-29.

195. Sabe L., Jason L., Juejati M. et al. Sensitivity and specificity of the MiniMental State Exam in the diagnosis of dementia. Behaviour. Neurol. 1993; 6: 4: 207210.

196. Sanders C, Egger M, Donovan J, Tallon D, Frankel S. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ 1998; 317:1191-1194.

197. Santini M., Casini A.R, Ferretti C., Prencipe M. Hypertension as risk factor for cognitive impairment and dementia in an elderly rural population. Europ. J. Neurol. 1997; 4: Suppll.: S134.

198. Saponaro S.A., Flanders A.E., Friedman D.P., Mandel S. J Neuroimaging 1994; 4; 48-50.

199. Savi P., Laplace M„ Maffrand J., Herbert J. Binding of (H)-2-methylthio ADP to rat platelets: effect of Clopidogrel and ticlopidine. J. Pharmacol. Exp. Ther. 1994; 269: 772-777.

200. Savi P., Heilmann E., Nurden P. Clopidogrel: an antithrombotic drug action oh the ADP-dependent activation pathway of human platelets. Clin. Appl. Thtomb. Hemost. 1996; 2: 35-42.

201. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patient with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389

202. Schmidt R., Lechner H. The importance of vascular risk factors in normal I ageing In: 7IPA Congress. Sydney, Australia, 1995. Abstracts, 61.

203. Shep Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated hypertension: Final results of the Systolic Hypertension in Elderly Program (SHEP). JAMA 265:3255-3264, 1991.

204. Shepherd J., Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307.

205. Sherman S. Short scales were as effective as long scales in screening for depression in older patients Commentary. Evid. Based. Med. 2001 ;6: 187.

206. Skoog J. Risk factors for vascular dementia: A review. In: Vascular Dementia. Etiological, Pathogenetic, Clinical and Treatment Aspects. Ed. by L.ACarlson, C.G.Gottfries, B.Winblad. -Basel etc.: S.Karger, 1994. -P.9-16.

207. The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-135.

208. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel.releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001;108:74.86.

209. Sultzer D.L., Mahler M.E., Cummings J.L. et al. Cortical abnormalities associated with subcortical lesions in vascular dementia: clinical and positron emission tomographic findings. Arch. Neurol. 1995; 52: 773-780.

210. Szatmary S., Fekete 1., Csiba L. et al. Cognitive impairment in cerebrovascular disease: screening on Hungarian cohort. Europ. J. Neurol. 1997; 4; Supp I: P.S146.

211. Tagawa K., Fukuhara M., Takenoyama T., Eno K. Effect of aging on cerebral blood flow in patients with brain infarction. In: 5 Asia/Oceania Regional Congress of rontology (19-23 November 1995, Hong Kong). Final Programme and Abstracts. -P. 144.

212. Tatemichi O.E., Foulkes M.A., Mohr J.P. et al. Dementia in stroke survivors in the Stroke Data Bank cohort : prevalence, incidence, risk factors, and computed tomographic findings. Stroke 1990; 21:858-866.

213. Tatemichi O.E., Desmond D.W., Paitz M. et al. The "Mini-Mental State" examination as a screen for dementia following stroke abstract., J. Clin. Exp. Neuropsychol. 1991; 13:419.

214. Tatemichi T.K., Desmond D., Prochovnik 1. et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 1992; 42: 1966-1979.

215. Tatemichi O.E., Paik M., Bagiella E. et al. Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study. Neurology 1994; 44: 1885-1891.

216. Tomlinson BE., Blessed G., Roth M. Observations on the brains of demented old people. J. Neurol. Sei. 1970; II: 205-242.

217. Tomonaga M., Yamanouchi H., Tohgi H., Kameyama M. Clinicopathologic study of progressive subcortical vascular encephalopathy (Binswangens type) in the elderly. J. AM. Geriatr. Soc. 1982; 30: 524-529.

218. Weinberger J. Stroke and TIA. Prevention and management of cerebrovascular events in primary care. Geriatrics. 2002;57(1 > 38-43.

219. Weiser M., Ctrosser W., Klein P. Homeopathic vs traditional Treatment of Vertigo. Arch. Otolaryngol. Head Neck Surg. 1998; 124: 879-885.

220. Wertheimer J. Clinical assessment of cerebro-active drugs. In: Dementia and cognitive impairments. Eds.Vellas B. J. et al. Facts and research in gerontology. 1994 (Supplement). -P. 161-170.

221. Wetterling T., Kanitz R.D., Borgis K.J. The ICD-10 criteria for vascular dementia. In: Vascular Dementia. Etiological, Pathogenetic, Clinical and Treatment Aspects. Ed. by L.A.Carlson, C.G.Gottfries, B.Winblad. -Basel etc.: S.Karger, 1994. -P.57-60.

222. Wetterling T. How to diagnose vascular dementia?. Europ. J. Neurol. -1997. -Vol.4, SuppLI. -P.S30.

223. WHO, Division of Mental Health. The neurological adaptation of the international classification of diseases, 10 Revision. (I.C.D.-10NA). Geneva, 1991.

224. World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioral Disorders. Clinical descriptions and diagnostic guidelines. Geneva, World Health Organization, 1992:50-51.

225. Wragg R.E., Jeste D.J. Overview of comorbidity in dementia-depression syndromes. Int J Psychiatry. 1989; 146: 577-587.

226. Yamanouchi H., Sugiura S., Tomonago M. Decrease in nerve fibres in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type. An electron microscopic study. J. Neurol. 1989; 236(7): 382-387.

227. Yoshitake T., Kiyohara Y., Kato 1., et al. Incidence and risk factors of vascular dementia and Aizheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 1995; 45:1161-1168.

228. Zapotoczky H. Problems of differential diagnosis between depressive pseudodementia and Aizheimer's disease. J. Neural. Trans. 1998; S.53: 91-95.

229. Zaudig M. A new systematic method of measurement and diagnosis of "mild cognitive impairment" and dementia according to ICD-10 and DSM-M-R criteria. Psychogeriatr. 1992; 4; Suppl.2: 203-219.